Article Versions Notes

Han C, Sun T, Chirumamilla SK, Bois FY, Xu M, Rostami-Hodjegan A. Understanding Discordance between In Vitro Dissolution, Local Gut and Systemic Bioequivalence of Budesonide in Healthy and Crohn’s Disease Patients through PBPK Modeling. Pharmaceutics. 2023; 15(9):2237. https://doi.org/10.3390/pharmaceutics15092237

Han, Chunyan, Tiancheng Sun, Siri Kalyan Chirumamilla, Frederic Y. Bois, Mandy Xu, and Amin Rostami-Hodjegan. 2023. "Understanding Discordance between In Vitro Dissolution, Local Gut and Systemic Bioequivalence of Budesonide in Healthy and Crohn’s Disease Patients through PBPK Modeling" Pharmaceutics 15, no. 9: 2237. https://doi.org/10.3390/pharmaceutics15092237

Han, C., Sun, T., Chirumamilla, S. K., Bois, F. Y., Xu, M., & Rostami-Hodjegan, A. (2023). Understanding Discordance between In Vitro Dissolution, Local Gut and Systemic Bioequivalence of Budesonide in Healthy and Crohn’s Disease Patients through PBPK Modeling. Pharmaceutics, 15(9), 2237. https://doi.org/10.3390/pharmaceutics15092237